Zobrazeno 1 - 10
of 122
pro vyhledávání: '"Lianchun Xiao"'
Autor:
Matheus Sewastjanow-Silva, Lianchun Xiao, Graciela N. Gonzalez, Xuemei Wang, Wayne Hofstetter, Stephen Swisher, Reza Mehran, Boris Sepesi, Manoop S. Bhutani, Brian Weston, Emmanuel Coronel, Rebecca E. Waters, Jane E. Rogers, Jackie Smith, Larry Lyons, Norelle Reilly, James C. Yao, Jaffer A. Ajani, Mariela Blum Murphy
Publikováno v:
Cancers, Vol 16, Iss 7, p 1378 (2024)
Efforts to improve the prognosis for patients with locally advanced esophageal or gastroesophageal junction (GEJ) adenocarcinoma have focused on neoadjuvant approaches to increase the pathological complete response (pathCR) rate, improve surgical res
Externí odkaz:
https://doaj.org/article/533a2850c2104c17ba949fc273f9c1c0
Autor:
Haoling Wang, Dongqiong Li, Youli Wang, Guangjian Mao, Guozhou Lu, Qiqin Lan, Lianchun Xiao, Wenjuan Tang, Yiqi Liu
Publikováno v:
Journal of International Medical Research, Vol 51 (2023)
Objective This study aimed to investigate the clinical significance of serum S100 calcium-binding protein A12 (S100A12) concentrations in patients with community-acquired pneumonia (CAP). Methods This was a case–control study. We selected 120 patie
Externí odkaz:
https://doaj.org/article/2a8b831f65064b5fa56cc8c7a7034cc4
Autor:
Omar Alhalabi, Matthew T. Campbell, Lianchun Xiao, Ana C. Adriazola, Nathaniel R. Wilson, Arlene O. Siefker‐Radtke, Paul G. Corn, Amado Zurita, Eric Jonasch, Jianjun Gao, Mehrad Adibi, Ashish M. Kamat, Neema Navai, Louis L. Pisters, Colin Dinney, Surena F. Matin, Amishi Y. Shah
Publikováno v:
BJUI Compass, Vol 3, Iss 1, Pp 37-44 (2022)
Abstract Objectives Multimodal kidney‐preserving (MKP) strategies may be an option for patients with localised or locally advanced high‐risk upper tract urothelial carcinoma (UTUC) who have a relative contraindication for nephroureterectomy (NU).
Externí odkaz:
https://doaj.org/article/4bec1710d1984582ada90fc20a09d76b
Autor:
Jane E. Rogers, Amanda Sirisaengtaksin, Michael Leung, Van K. Morris, Lianchun Xiao, Ryan Huey, Robert Wolff, Cathy Eng, Jean Nicolas Vauthey, Ching-Wei D. Tzeng, Benny Johnson
Publikováno v:
Cancers, Vol 15, Iss 15, p 3890 (2023)
Background: Squamous cell carcinoma of the anal canal (SCCA) is rare. Most cases are diagnosed in a localized setting. Metastatic SCCA is rare, and investigation has been limited in the past for these patients. We believe that hepatic-only metastatic
Externí odkaz:
https://doaj.org/article/14922063623f48cbb16b9fbe08fb50db
Autor:
Ahmed O. Kaseb, Abedul Haque, Deeksha Vishwamitra, Manal M. Hassan, Lianchun Xiao, Bhawana George, Vishal Sahu, Yehia I. Mohamed, Roberto Carmagnani Pestana, Jamie Lynne Lombardo, Rony Avritscher, James C. Yao, Robert A. Wolff, Asif Rashid, Jeffrey S. Morris, Hesham M. Amin
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Hepatocellular carcinoma (HCC) is an aggressive neoplasm with poor clinical outcome because most patients present at an advanced stage, at which point curative surgical options, such as tumor excision or liver transplantation, are not feasible. There
Externí odkaz:
https://doaj.org/article/224741d9023048d79f5c82c97fdcee84
Autor:
Andrew L. Laccetti, Benjamin Garmezy, Lianchun Xiao, Minas Economides, Aradhana Venkatesan, Jianjun Gao, Eric Jonasch, Paul Corn, Amado Zurita‐Saavedra, Landon C. Brown, Chester Kao, Emily N. Kinsey, Rajan T. Gupta, Michael R. Harrison, Andrew J. Armstrong, Daniel J. George, Nizar Tannir, Pavlos Msaouel, Amishi Shah, Tian Zhang, Matthew T. Campbell
Publikováno v:
Cancer Medicine, Vol 10, Iss 7, Pp 2341-2349 (2021)
Abstract Introduction Two separate antiangiogenic tyrosine kinase inhibitors (TKIs) and immunotherapy (IO) combinations are FDA‐approved as front‐line treatment for metastatic renal cell carcinoma (mRCC). Little is known about off‐protocol and
Externí odkaz:
https://doaj.org/article/93fb0ccf60b5470ca6cdd487ce1a82ce
Autor:
Patrick K. Reville, Hagop M. Kantarjian, Farhad Ravandi, Elias Jabbour, Courtney D. DiNardo, Naval Daver, Naveen Pemmaraju, Maro Ohanian, Yesid Alvarado, Lianchun Xiao, Gheath Alatrash, Sanam Loghavi, Caitlin R. Rausch, Gautam Borthakur, Marina Konopleva, Jorge Cortes, Tapan M. Kadia
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 3, Pp 1-5 (2021)
Externí odkaz:
https://doaj.org/article/8f2495e6bad446078d3349076adbe94b
Autor:
Jane E. Rogers, Jonathan D. Mizrahi, Lianchun Xiao, Chirayu Mohindroo, Rachna T. Shroff, Robert Wolff, Gauri R. Varadhachary, Milind M. Javle, Michael Overman, David R. Fogelman, Kanwal P. S. Raghav, Shubham Pant, Florencia McAllister
Publikováno v:
Cancer Medicine, Vol 9, Iss 15, Pp 5406-5415 (2020)
Abstract Background Gemcitabine (GEM) plus nab‐paclitaxel (NabP) (GEM 1000 mg/m2 IV over 30 minutes + NabP 125 mg/m2 IV given days 1, 8, and 15 every 28 days) is one of the two standard of care combination therapies for metastatic pancreatic ductal
Externí odkaz:
https://doaj.org/article/661f185a502f41a69c6a00dc6f1e1360
Autor:
Ryan W. Huey, Shalini Makawita, Lianchun Xiao, Aurelio Matamoros, Jeannelyn S. Estrella, Michael J. Overman, Gauri R. Varadhachary, Kanwal Raghav
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)
Abstract Background Sarcomatoid carcinoma of unknown primary (SCUP) is a rare entity of either poorly differentiated carcinoma with sarcoma-like differentiation or a true mixed lineage neoplasm. Limited data regarding clinicopathological profile and
Externí odkaz:
https://doaj.org/article/26c32ce648f74336b3686e1b70e4c600
Autor:
Jennifer Wang, Jianjun Gao, Chad Tang, Arlene Siefker-Radtke, Nizar Tannir, Ana Aparicio, Christopher Logothetis, Lianchun Xiao, Matthew Campbell, Omar Alhalabi, Nathaniel Wilson, Elshad Hasanov, John Papadopoulos, Paul Corn, Bogdan Czerniak, Charles Guo, Seungtaek Choi
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/ba2000bad25742979f2f4f0f036ce811